Impax Opens New Front In Adderall Battle With Shire
Impax Laboratories Inc. is taking action against the newest patent issued for anti-depressant Adderall XR, countersuing Shire Laboratories Inc. in federal court. At the same time, Shire is lobbying the FDA...To view the full article, register now.
Already a subscriber? Click here to view full article